ROHAN PALEKAR - 23 Mar 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Issuer symbol
ETNB
Transactions as of
23 Mar 2023
Transactions value $
-$240,000
Form type
4
Filing time
27 Mar 2023, 19:18:38 UTC
Previous filing
22 Feb 2023
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Sale -$240,000 -15,000 -5.3% $16 269,080 23 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 15, 2022.
F2 Includes an aggregate of 8 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 30, 2022.